MSD MASTIJET – FORTE 20 X 9 ml VET ONLY (S4)

R1 190,15 excl.

PHARMACOLOGICAL ACTION

Mastijet® Forte is a broad-spectrum antimicrobial mastitis formulation combined with a corticosteroid.

INDICATIONS

Mastijet® Forte is indicated for the treatment of mastitis in cows, including severe mastitis caused by susceptible micro-organisms.

CONTRAINDICATIONS

None.

WARNINGS

Withdrawal period:

The milk from treated quarters must not be used for human consumption during the treatment period and for 8 milkings following the last infusion.
Milk from untreated quarters must also be withheld during treatment and for one milking after last infusion.
Following the last infusion, the meat should not be used for human consumption within 2 days, the udder tissue within 14 days and the organs within 42 days.
DOSAGE AND DIRECTIONS FOR USE

Infuse entire contents of one syringe into each infected quarter. In severe cases, the treatment may be repeated at a 24-hour interval.
Shake syringe before use.
Milk quarter completely. Clean teat thoroughly.
Remove the cover of the syringe tip, insert tip into the teat canal and inject the entire content of the syringe.
Remove the syringe, grasp the end of the teat firmly and massage the teat upwards, thus massaging the content of the teat into the quarter.
SIDE EFFECTS AND SPECIAL PRECAUTIONS

Mastijet® Forte administered in therapeutic doses is well tolerated. During all closely observed experiments and field trials, no side effects were observed in either normal quarters or mastitis quarters. In chronic cases of mastitis, where there could have been overgrowth by resistant bacteria or anaerobes or moulds, it is sound practice to first establish the causative organisms and their sensitivity.

INTERACTIONS

None.

KNOWN SIGNS OF OVERDOSAGE AND TREATMENT

No signs of overdosage have been described.

IDENTIFICATION

A yellow, creamy suspension packed in a white plastic disposable syringe with an injector tip.

PRESENTATION

Cartons containing 20 x 8 g polyethylene syringes packed in aluminium foil sachets.

Cleaning towels and a package insert are also included.

STORAGE

Store between 2 °C to 8 ºC. Protect from light.

KEEP OUT OF REACH OF CHILDREN AND UNINFORMED PERSONS AND ANIMALS.

REFERENCE NUMBER

83/760 (Act 101/1965)

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS SCIENTIFIC PACKAGE INSERT

30 April 2018

ZIMBABWE ONLY
Registration number: 2002/80.21/9597
Pharmacological classification: 80.21 – Intramammary preparations
Category for Distribution:(VET): PP

SKU: 069619 Category:

Description

Registration No:83/790
Scheduled product. For further information please consult your veterinarian

VETERINARY MEDICINE

[S4] MASTIJET® FORTE

INTRAMAMMARY SUSPENSION

COMPOSITION

Each 8 g syringe contains:

Tetracycline hydrochloride 200 mg

Neomycin base 250 mg

Bacitracin 2 000 IU

Prednisolone 10 mg

PHARMACOLOGICAL CLASSIFICATION

C 16.1 Intramammary Suspension: Antimicrobials